These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16317101)

  • 1. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
    Schiemann F; Grimm TA; Hoch J; Gross R; Lindner B; Petersen F; Bulfone-Paus S; Brandt E
    Blood; 2006 Mar; 107(6):2234-42. PubMed ID: 16317101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
    Schenk BI; Petersen F; Flad HD; Brandt E
    J Immunol; 2002 Sep; 169(5):2602-10. PubMed ID: 12193731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
    Car BD; Baggiolini M; Walz A
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
    Brandt E; Van Damme J; Flad HD
    Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
    Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
    J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
    Härter L; Petersen F; Flad HD; Brandt E
    J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of the neutrophil-activating peptide-2 by cathepsin G and cathepsin G-treated human platelets.
    Cohen AB; Stevens MD; Miller EJ; Atkinson MA; Mullenbach G
    Am J Physiol; 1992 Aug; 263(2 Pt 1):L249-56. PubMed ID: 1387511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
    Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
    Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the primary structures of human skin chymase and cathepsin G from cutaneous mast cells of urticaria pigmentosa lesions.
    Schechter NM; Wang ZM; Blacher RW; Lessin SR; Lazarus GS; Rubin H
    J Immunol; 1994 Apr; 152(8):4062-9. PubMed ID: 8144971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel, potent dual inhibitor of the leukocyte proteases cathepsin G and chymase: molecular mechanisms and anti-inflammatory activity in vivo.
    de Garavilla L; Greco MN; Sukumar N; Chen ZW; Pineda AO; Mathews FS; Di Cera E; Giardino EC; Wells GI; Haertlein BJ; Kauffman JA; Corcoran TW; Derian CK; Eckardt AJ; Damiano BP; Andrade-Gordon P; Maryanoff BE
    J Biol Chem; 2005 May; 280(18):18001-7. PubMed ID: 15741158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of substance P and bradykinin by human neutrophils.
    Skidgel RA; Jackman HL; Erdös EG
    Biochem Pharmacol; 1991 May; 41(9):1335-44. PubMed ID: 1708255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
    Walz A; Dewald B; von Tscharner V; Baggiolini M
    J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G.
    Owen CA; Campbell MA; Boukedes SS; Campbell EJ
    J Immunol; 1995 Dec; 155(12):5803-10. PubMed ID: 7499869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibition of mast cell activation by neutrophil lactoferrin: uptake by mast cells and interaction with tryptase, chymase and cathepsin G.
    He S; McEuen AR; Blewett SA; Li P; Buckley MG; Leufkens P; Walls AF
    Biochem Pharmacol; 2003 Mar; 65(6):1007-15. PubMed ID: 12623133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin I conversion by human and rat chymotryptic proteinases.
    Wintroub BU; Schechter NB; Lazarus GS; Kaempfer CE; Schwartz LB
    J Invest Dermatol; 1984 Nov; 83(5):336-9. PubMed ID: 6092480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
    Brandt E; Petersen F; Ludwig A; Ehlert JE; Bock L; Flad HD
    J Leukoc Biol; 2000 Apr; 67(4):471-8. PubMed ID: 10770278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S; Gaça MD; McEuen AR; Walls AF
    J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
    Rennen HJ; Frielink C; Brandt E; Zaat SA; Boerman OC; Oyen WJ; Corstens FH
    J Nucl Med; 2004 Jul; 45(7):1217-23. PubMed ID: 15235069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.